Compounded semaglutide stabilizes the chaos
If successful, RJVA-001 could transform how we think about [type 2 diabetes], from a chronic disease you manage every day to one that could potentially be treated once.
Patients in participating plans would pay something like the current Bridge copay, but the cost would shift from the federal government to the insurer
SURMOUNT-1 Trial (New England Journal of Medicine, 2022) Randomized, double-blind, placebo-controlled 2,539 participants 72 weeks NCT04184622 Tirzepatide 5 mg -16.0% Mean body weight reduction Tirzepatide 10 mg -21.4% Mean body weight reduction Tirzepatide 15 mg -22.5% Mean body weight reduction Placebo group: -2.4% All results statistically significant (p 27 with Comorbidities Overweight or obese patients (Indian cutoff BMI 23+ with risk factors) seeking significant, sustained weight loss
What It Treats Metabolic Health Mental Clarity Nutrient Deficiencies Weight Management Energy Levels Skin and Hair Health Supply Your Body With the Right Nutrients Needing a boost when it comes to your wellness goals